O	0	4	RhoA	RhoA	NN	B-NP
O	5	15	activation	activation	NN	I-NP
O	16	24	promotes	promote	VBZ	B-VP
O	25	39	transformation	transformation	NN	B-NP
O	40	43	and	and	CC	I-NP
O	44	48	loss	loss	NN	I-NP
O	49	51	of	of	IN	B-PP
B-Cell	52	59	thyroid	thyroid	NN	B-NP
I-Cell	60	64	cell	cell	NN	I-NP
O	65	80	differentiation	differentiation	NN	I-NP
O	81	92	interfering	interfere	VBG	B-VP
O	93	97	with	with	IN	B-PP
O	98	105	thyroid	thyroid	NN	B-NP
O	106	119	transcription	transcription	NN	I-NP
O	120	126	factor	factor	NN	I-NP
O	126	127	-	-	HYPH	B-NP
O	127	128	1	1	CD	I-NP
O	129	137	activity	activity	NN	I-NP
O	137	138	.	.	.	O

O	140	146	Highly	Highly	RB	B-NP
O	147	158	specialized	specialize	VBN	I-NP
B-Cell	159	164	cells	cell	NNS	I-NP
O	164	165	,	,	,	O
O	166	169	the	the	DT	B-NP
B-Cell	170	180	thyrocytes	thyrocyte	NNS	I-NP
O	180	181	,	,	,	O
O	182	189	express	express	VBP	B-VP
O	190	191	a	a	DT	B-NP
B-Organ	192	199	thyroid	thyroid	NN	I-NP
O	199	200	-	-	HYPH	B-NP
O	200	208	specific	specific	JJ	I-NP
O	209	212	set	set	NN	I-NP
O	213	215	of	of	IN	B-PP
O	216	221	genes	gene	NNS	B-NP
O	222	225	for	for	IN	B-PP
O	226	239	thyroglobulin	thyroglobulin	NN	B-NP
O	240	241	(	(	(	O
O	241	243	Tg	Tg	NN	B-NP
O	243	244	)	)	)	O
O	244	245	,	,	,	O
O	246	261	thyroperoxidase	thyroperoxidase	NN	B-NP
O	261	262	,	,	,	O
O	263	266	and	and	CC	O
O	267	270	the	the	DT	B-NP
O	271	284	transcription	transcription	NN	I-NP
O	285	292	factors	factor	NNS	I-NP
O	293	296	TTF	TTF	NN	B-NP
O	296	297	-	-	HYPH	B-NP
O	297	298	1	1	CD	I-NP
O	298	299	,	,	,	O
O	300	303	TTF	TTF	NN	B-NP
O	303	304	-	-	HYPH	O
O	304	305	2	2	CD	B-NP
O	305	306	,	,	,	O
O	307	310	and	and	CC	O
O	311	314	Pax	Pax	NN	B-NP
O	314	315	-	-	:	O
O	315	316	8	8	CD	B-NP
O	316	317	.	.	.	O

O	318	321	The	The	DT	B-NP
O	322	333	implication	implication	NN	I-NP
O	334	336	of	of	IN	B-PP
O	337	340	the	the	DT	B-NP
O	341	346	small	small	JJ	I-NP
O	347	353	GTPase	GTPase	NN	I-NP
O	354	358	RhoA	RhoA	NN	I-NP
O	359	361	in	in	IN	B-PP
O	362	365	TSH	TSH	NN	B-NP
O	365	366	-	-	HYPH	B-NP
O	366	374	mediated	mediate	VBN	I-NP
O	375	388	proliferation	proliferation	NN	I-NP
O	389	391	of	of	IN	B-PP
B-Cell	392	396	FRTL	FRTL	NN	B-NP
I-Cell	396	397	-	-	HYPH	B-NP
I-Cell	397	398	5	5	CD	I-NP
I-Cell	399	402	rat	rat	NN	I-NP
I-Cell	403	410	thyroid	thyroid	NN	I-NP
I-Cell	411	416	cells	cell	NNS	I-NP
O	417	420	has	have	VBZ	B-VP
O	421	425	been	be	VBN	I-VP
O	426	436	previously	previously	RB	I-VP
O	437	449	demonstrated	demonstrate	VBN	I-VP
O	449	450	.	.	.	O

O	451	453	To	To	TO	B-VP
O	454	461	further	further	RBR	I-VP
O	462	469	analyze	analyze	VB	I-VP
O	470	474	RhoA	RhoA	NN	B-NP
O	475	483	function	function	NN	I-NP
O	484	486	in	in	IN	B-PP
B-Cell	487	494	thyroid	thyroid	JJ	B-NP
I-Cell	495	499	cell	cell	NN	I-NP
O	500	513	proliferation	proliferation	NN	I-NP
O	514	517	and	and	CC	O
O	518	533	differentiation	differentiation	NN	B-NP
O	534	542	patterns	pattern	NNS	I-NP
O	542	543	,	,	,	O
O	544	546	we	we	PRP	B-NP
O	547	555	combined	combine	VBD	B-VP
O	556	565	transient	transient	JJ	B-NP
O	566	569	and	and	CC	I-NP
O	570	576	stable	stable	JJ	I-NP
O	577	589	transfection	transfection	NN	I-NP
O	590	596	assays	assay	NNS	I-NP
O	597	599	to	to	TO	B-VP
O	600	607	express	express	VB	I-VP
O	608	617	different	different	JJ	B-NP
O	618	624	mutant	mutant	JJ	I-NP
O	625	629	RhoA	RhoA	NN	I-NP
O	630	635	forms	form	NNS	I-NP
O	636	638	in	in	IN	B-PP
B-Cell	639	643	FRTL	FRTL	NN	B-NP
I-Cell	643	644	-	-	HYPH	O
I-Cell	644	645	5	5	CD	B-NP
I-Cell	646	651	cells	cell	NNS	I-NP
O	651	652	.	.	.	O

O	653	667	Constitutively	Constitutively	RB	B-NP
O	668	674	active	active	JJ	I-NP
O	675	679	RhoA	RhoA	NN	I-NP
O	680	681	(	(	(	O
B-Cell	681	685	FRTL	FRTL	NN	B-NP
I-Cell	685	686	-	-	HYPH	B-NP
I-Cell	686	687	5	5	CD	I-NP
I-Cell	687	688	-	-	HYPH	I-NP
I-Cell	688	692	RhoA	RhoA	NN	I-NP
I-Cell	693	695	QL	QL	NN	I-NP
I-Cell	696	701	cells	cell	NNS	I-NP
O	701	702	)	)	)	O
O	703	712	exhibited	exhibit	VBD	B-VP
O	713	714	a	a	DT	B-NP
B-Cell	715	725	fibroblast	fibroblast	NN	I-NP
O	725	726	-	-	HYPH	B-NP
O	726	730	like	like	JJ	I-NP
O	731	740	phenotype	phenotype	NN	I-NP
O	741	745	with	with	IN	B-PP
O	746	755	organized	organize	VBN	B-NP
B-Cellular_component	756	761	actin	actin	NN	I-NP
I-Cellular_component	762	768	fibers	fiber	NNS	I-NP
O	768	769	,	,	,	O
O	770	777	whereas	whereas	IN	B-PP
B-Cell	778	783	cells	cell	NNS	B-NP
O	784	794	expressing	express	VBG	B-VP
O	795	798	the	the	DT	B-NP
O	799	803	RhoA	RhoA	NN	I-NP
O	804	812	negative	negative	JJ	I-NP
O	813	821	dominant	dominant	JJ	I-NP
O	822	831	phenotype	phenotype	NN	I-NP
O	832	833	(	(	(	O
B-Cell	833	837	FRTL	FRTL	NN	B-NP
I-Cell	837	838	-	-	HYPH	B-NP
I-Cell	838	839	5	5	CD	I-NP
I-Cell	839	840	-	-	HYPH	I-NP
I-Cell	840	844	RhoA	RhoA	NN	I-NP
I-Cell	845	848	N19	N19	NN	I-NP
I-Cell	849	854	cells	cell	NNS	I-NP
O	854	855	)	)	)	O
O	856	863	present	present	VBP	B-VP
O	864	865	a	a	DT	B-NP
O	866	873	rounded	rounded	JJ	I-NP
O	874	884	morphology	morphology	NN	I-NP
O	885	888	and	and	CC	O
O	889	893	lose	lose	VBP	B-VP
O	894	900	normal	normal	JJ	B-NP
B-Cellular_component	901	913	cytoskeletal	cytoskeletal	JJ	I-NP
O	914	926	architecture	architecture	NN	I-NP
O	926	927	.	.	.	O

O	928	930	In	In	IN	B-PP
O	931	939	addition	addition	NN	B-NP
O	939	940	,	,	,	O
O	941	951	expression	expression	NN	B-NP
O	952	954	of	of	IN	B-PP
O	955	958	the	the	DT	B-NP
O	959	973	constitutively	constitutively	RB	I-NP
O	974	980	active	active	JJ	I-NP
O	981	985	form	form	NN	I-NP
O	986	988	of	of	IN	B-PP
O	989	993	RhoA	RhoA	NN	B-NP
O	994	1001	results	result	VBZ	B-VP
O	1002	1004	in	in	IN	B-PP
O	1005	1008	TSH	TSH	NN	B-NP
O	1008	1009	-	-	HYPH	B-NP
O	1009	1020	independent	independent	JJ	I-NP
O	1021	1034	proliferation	proliferation	NN	I-NP
O	1035	1038	and	and	CC	I-NP
O	1039	1048	anchorage	anchorage	NN	I-NP
O	1048	1049	-	-	HYPH	B-NP
O	1049	1060	independent	independent	JJ	I-NP
O	1061	1067	growth	growth	NN	I-NP
O	1068	1071	and	and	CC	O
O	1072	1079	induces	induce	VBZ	B-VP
B-Cancer	1080	1086	tumors	tumor	NNS	B-NP
O	1087	1091	when	when	WRB	B-ADVP
O	1092	1102	inoculated	inoculate	VBN	B-VP
O	1103	1105	in	in	IN	B-PP
O	1106	1110	nude	nude	JJ	B-NP
O	1111	1115	mice	mouse	NNS	I-NP
O	1115	1116	.	.	.	O

O	1117	1130	Interestingly	Interestingly	RB	B-ADVP
O	1130	1131	,	,	,	O
B-Cell	1132	1136	FRTL	FRTL	NN	B-NP
I-Cell	1136	1137	-	-	HYPH	B-NP
I-Cell	1137	1138	5	5	CD	I-NP
I-Cell	1138	1139	-	-	HYPH	I-NP
I-Cell	1139	1143	RhoA	RhoA	NN	I-NP
I-Cell	1144	1146	QL	QL	NN	I-NP
I-Cell	1147	1152	cells	cell	NNS	I-NP
O	1153	1160	express	express	VBP	B-VP
O	1161	1165	less	less	JJR	B-NP
O	1166	1168	Tg	Tg	NN	I-NP
O	1169	1172	and	and	CC	I-NP
O	1173	1176	TTF	TTF	NN	I-NP
O	1176	1177	-	-	HYPH	B-NP
O	1177	1178	1	1	CD	I-NP
O	1179	1183	than	than	IN	B-PP
O	1184	1188	wild	wild	JJ	B-NP
O	1188	1189	-	-	HYPH	I-NP
O	1189	1193	type	type	NN	I-NP
B-Cell	1194	1198	FRTL	FRTL	NN	I-NP
I-Cell	1198	1199	-	-	HYPH	O
I-Cell	1199	1200	5	5	CD	B-NP
O	1201	1202	(	(	(	O
B-Cell	1202	1206	FRTL	FRTL	NN	B-NP
I-Cell	1206	1207	-	-	HYPH	B-NP
I-Cell	1207	1208	5	5	CD	I-NP
O	1208	1209	-	-	HYPH	I-NP
O	1210	1216	vector	vector	NN	I-NP
O	1216	1217	)	)	)	O
O	1218	1220	or	or	CC	O
B-Cell	1221	1225	FRTL	FRTL	NN	B-NP
I-Cell	1225	1226	-	-	HYPH	B-NP
I-Cell	1226	1227	5	5	CD	I-NP
I-Cell	1227	1228	-	-	HYPH	I-NP
I-Cell	1228	1232	RhoA	RhoA	NN	I-NP
I-Cell	1233	1236	N19	N19	NN	I-NP
O	1236	1237	,	,	,	O
O	1238	1248	suggesting	suggest	VBG	B-VP
O	1249	1250	a	a	DT	B-NP
O	1251	1255	loss	loss	NN	I-NP
O	1256	1258	at	at	IN	B-PP
O	1259	1262	the	the	DT	B-NP
O	1263	1278	differentiation	differentiation	NN	I-NP
O	1279	1284	stage	stage	NN	I-NP
O	1284	1285	.	.	.	O

O	1286	1290	This	This	DT	B-NP
O	1291	1297	effect	effect	NN	I-NP
O	1298	1300	is	be	VBZ	B-VP
O	1301	1309	mediated	mediate	VBN	I-VP
O	1309	1310	,	,	,	O
O	1311	1313	at	at	IN	B-ADVP
O	1314	1319	least	least	JJS	I-ADVP
O	1320	1322	in	in	IN	B-PP
O	1323	1327	part	part	NN	B-NP
O	1327	1328	,	,	,	O
O	1329	1331	by	by	IN	B-PP
O	1332	1333	a	a	DT	B-NP
O	1334	1342	decrease	decrease	NN	I-NP
O	1343	1345	in	in	IN	B-PP
O	1346	1349	TTF	TTF	NN	B-NP
O	1349	1350	-	-	HYPH	B-NP
O	1350	1351	1	1	CD	I-NP
O	1352	1360	activity	activity	NN	I-NP
O	1360	1361	,	,	,	O
O	1362	1367	since	since	IN	B-SBAR
O	1368	1377	transient	transient	JJ	B-NP
O	1378	1380	or	or	CC	I-NP
O	1381	1387	stable	stable	JJ	I-NP
O	1388	1398	expression	expression	NN	I-NP
O	1399	1401	of	of	IN	B-PP
B-Cell	1402	1406	RhoA	RhoA	NN	B-NP
I-Cell	1407	1409	QL	QL	NN	I-NP
O	1410	1417	results	result	VBZ	B-VP
O	1418	1420	in	in	IN	B-PP
O	1421	1422	a	a	DT	B-NP
O	1423	1432	reduction	reduction	NN	I-NP
O	1433	1435	in	in	IN	B-PP
O	1436	1439	the	the	DT	B-NP
O	1440	1448	activity	activity	NN	I-NP
O	1449	1451	of	of	IN	B-PP
O	1452	1455	the	the	DT	B-NP
O	1456	1460	wild	wild	JJ	I-NP
O	1460	1461	-	-	HYPH	I-NP
O	1461	1465	type	type	NN	I-NP
O	1466	1468	Tg	Tg	NN	I-NP
O	1469	1477	promoter	promoter	NN	I-NP
O	1478	1480	as	as	RB	B-CONJP
O	1481	1485	well	well	RB	I-CONJP
O	1486	1488	as	as	IN	I-CONJP
O	1489	1491	an	an	DT	B-NP
O	1492	1502	artificial	artificial	JJ	I-NP
O	1503	1511	promoter	promoter	NN	I-NP
O	1512	1515	the	the	DT	B-NP
O	1516	1526	activation	activation	NN	I-NP
O	1527	1529	of	of	IN	B-PP
O	1530	1535	which	which	WDT	B-NP
O	1536	1543	depends	depend	VBZ	B-VP
O	1544	1555	exclusively	exclusively	RB	B-ADVP
O	1556	1558	on	on	IN	B-PP
O	1559	1562	TTF	TTF	NN	B-NP
O	1562	1563	-	-	HYPH	B-NP
O	1563	1564	1	1	CD	I-NP
O	1564	1565	.	.	.	O

O	1566	1569	The	The	DT	B-NP
O	1570	1580	similarity	similarity	NN	I-NP
O	1581	1588	between	between	IN	B-PP
O	1589	1593	RhoA	RhoA	NN	B-NP
O	1594	1601	effects	effect	NNS	I-NP
O	1602	1605	and	and	CC	O
B-Cell	1606	1613	thyroid	thyroid	JJ	B-NP
O	1614	1628	transformation	transformation	NN	I-NP
O	1629	1631	by	by	IN	B-PP
O	1632	1635	Ras	Ras	NN	B-NP
O	1636	1644	suggests	suggest	VBZ	B-VP
O	1645	1649	that	that	IN	B-SBAR
O	1650	1654	RhoA	RhoA	NN	B-NP
O	1655	1658	may	may	MD	B-VP
O	1659	1662	act	act	VB	I-VP
O	1663	1665	as	as	IN	B-PP
O	1666	1667	a	a	DT	B-NP
O	1668	1678	downstream	downstream	JJ	I-NP
O	1679	1687	effector	effector	NN	I-NP
O	1688	1690	of	of	IN	B-PP
O	1691	1694	Ras	Ras	NN	B-NP
O	1694	1695	;	;	:	O
O	1696	1698	in	in	IN	B-PP
O	1699	1703	fact	fact	NN	B-NP
O	1703	1704	,	,	,	O
O	1705	1708	the	the	DT	B-NP
O	1709	1717	dominant	dominant	JJ	I-NP
O	1718	1726	negative	negative	JJ	I-NP
O	1727	1731	RhoA	RhoA	NN	I-NP
O	1732	1735	N19	N19	NN	I-NP
O	1736	1745	abolished	abolish	VBD	B-VP
O	1746	1749	the	the	DT	B-NP
O	1750	1754	down	down	RB	I-NP
O	1754	1755	-	-	HYPH	I-NP
O	1756	1766	regulatory	regulatory	JJ	I-NP
O	1767	1773	effect	effect	NN	I-NP
O	1774	1776	of	of	IN	B-PP
O	1777	1780	Ras	Ras	NN	B-NP
O	1781	1784	V12	V12	NN	I-NP
O	1785	1789	over	over	IN	B-PP
O	1790	1793	the	the	DT	B-NP
O	1794	1796	Tg	Tg	NN	I-NP
O	1797	1805	promoter	promoter	NN	I-NP
O	1805	1806	.	.	.	O

O	1807	1812	Taken	Take	VBN	B-VP
O	1813	1821	together	together	RB	B-ADVP
O	1821	1822	,	,	,	O
O	1823	1828	these	these	DT	B-NP
O	1829	1836	results	result	NNS	I-NP
O	1837	1841	show	show	VBP	B-VP
O	1842	1845	for	for	IN	B-PP
O	1846	1849	the	the	DT	B-NP
O	1850	1855	first	first	JJ	I-NP
O	1856	1860	time	time	NN	I-NP
O	1861	1865	that	that	IN	B-ADVP
O	1866	1872	active	active	JJ	B-NP
O	1873	1877	RhoA	RhoA	NN	I-NP
O	1878	1880	is	be	VBZ	B-VP
O	1881	1885	able	able	JJ	B-ADJP
O	1886	1888	to	to	TO	B-VP
O	1889	1898	transform	transform	VB	I-VP
B-Cell	1899	1903	FRTL	FRTL	NN	B-NP
I-Cell	1903	1904	-	-	HYPH	O
I-Cell	1904	1905	5	5	CD	B-NP
I-Cell	1906	1911	cells	cell	NNS	I-NP
O	1912	1915	and	and	CC	O
O	1916	1920	that	that	IN	B-SBAR
O	1921	1925	this	this	DT	B-NP
O	1926	1932	effect	effect	NN	I-NP
O	1933	1935	is	be	VBZ	B-VP
O	1936	1943	coupled	couple	VBN	I-VP
O	1944	1946	to	to	TO	B-PP
O	1947	1948	a	a	DT	B-NP
O	1949	1953	loss	loss	NN	I-NP
O	1954	1956	of	of	IN	B-PP
B-Cell	1957	1964	thyroid	thyroid	JJ	B-NP
O	1965	1980	differentiation	differentiation	NN	I-NP
O	1981	1984	due	due	JJ	B-PP
O	1985	1987	to	to	TO	B-PP
O	1988	1996	impaired	impair	VBN	B-NP
O	1997	2000	TTF	TTF	NN	I-NP
O	2000	2001	-	-	HYPH	B-NP
O	2001	2002	1	1	CD	I-NP
O	2003	2011	activity	activity	NN	I-NP
O	2011	2012	.	.	.	O

